Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-02

FDA Approved: ESTAZOLAM — Supplemental Application (Novitium Pharma LLC)

View source ↗

Summary

The FDA approves a supplemental application for Estazolam, with Novitium Pharma LLC as the sponsor, indicating an expansion/approval under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estazolam (Estazolam)

Snippet

SUPPL AP for ESTAZOLAM (ESTAZOLAM)